SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-031263
Filing Date
2023-11-09
Accepted
2023-11-09 16:15:17
Documents
14
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eton20231107c_8k.htm   iXBRL 8-K 26139
2 EXHIBIT 99.1 ex_593047.htm EX-99.1 152707
  Complete submission text file 0001437749-23-031263.txt   326558

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eton-20231109.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20231109_def.xml EX-101.DEF 11804
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20231109_lab.xml EX-101.LAB 15848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20231109_pre.xml EX-101.PRE 12019
8 EXTRACTED XBRL INSTANCE DOCUMENT eton20231107c_8k_htm.xml XML 2663
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38738 | Film No.: 231392618
SIC: 2834 Pharmaceutical Preparations